Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Salvage therapy in patients with glioblastoma: is there any benefit?
Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke M, Allgäuer M, Schuierer G, Koch H, Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A. Hau P, et al. Among authors: bogdahn u. Cancer. 2003 Dec 15;98(12):2678-86. doi: 10.1002/cncr.11845. Cancer. 2003. PMID: 14669289 Free article.
Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma.
Hau P, Fabel K, Baumgart U, Rümmele P, Grauer O, Bock A, Dietmaier C, Dietmaier W, Dietrich J, Dudel C, Hübner F, Jauch T, Drechsel E, Kleiter I, Wismeth C, Zellner A, Brawanski A, Steinbrecher A, Marienhagen J, Bogdahn U. Hau P, et al. Among authors: bogdahn u. Cancer. 2004 Mar 15;100(6):1199-207. doi: 10.1002/cncr.20073. Cancer. 2004. PMID: 15022287 Free article. Clinical Trial.
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study.
Beier CP, Schmid C, Gorlia T, Kleinletzenberger C, Beier D, Grauer O, Steinbrecher A, Hirschmann B, Brawanski A, Dietmaier C, Jauch-Worley T, Kölbl O, Pietsch T, Proescholdt M, Rümmele P, Muigg A, Stockhammer G, Hegi M, Bogdahn U, Hau P. Beier CP, et al. Among authors: bogdahn u. BMC Cancer. 2009 Sep 2;9:308. doi: 10.1186/1471-2407-9-308. BMC Cancer. 2009. PMID: 19725960 Free PMC article. Clinical Trial.
Temozolomide preferentially depletes cancer stem cells in glioblastoma.
Beier D, Röhrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP. Beier D, et al. Among authors: bogdahn u. Cancer Res. 2008 Jul 15;68(14):5706-15. doi: 10.1158/0008-5472.CAN-07-6878. Cancer Res. 2008. PMID: 18632623
Use of metformin and survival of patients with high-grade glioma.
Seliger C, Luber C, Gerken M, Schaertl J, Proescholdt M, Riemenschneider MJ, Meier CR, Bogdahn U, Leitzmann MF, Klinkhammer-Schalke M, Hau P. Seliger C, et al. Among authors: bogdahn u. Int J Cancer. 2019 Jan 15;144(2):273-280. doi: 10.1002/ijc.31783. Epub 2018 Oct 26. Int J Cancer. 2019. PMID: 30091464 Free article.
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.
Hau P, Jachimczak P, Schlingensiepen R, Schulmeyer F, Jauch T, Steinbrecher A, Brawanski A, Proescholdt M, Schlaier J, Buchroithner J, Pichler J, Wurm G, Mehdorn M, Strege R, Schuierer G, Villarrubia V, Fellner F, Jansen O, Straube T, Nohria V, Goldbrunner M, Kunst M, Schmaus S, Stauder G, Bogdahn U, Schlingensiepen KH. Hau P, et al. Among authors: bogdahn u. Oligonucleotides. 2007 Summer;17(2):201-12. doi: 10.1089/oli.2006.0053. Oligonucleotides. 2007. PMID: 17638524 Clinical Trial.
308 results